Alar Pharmaceuticals Inc. (TPEX: 6785)
Health Care · Pharmaceuticals · TW
NT$88.10
-6.97% today · -68.3% 1Y
Alar Pharmaceuticals Inc. (TPEX: 6785) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $184.05M and employs 32 people.
Over the last twelve months the share price has lost 68.3%, trading between 88.10 and 317.00.
Tweenvest scores Alar Pharmaceuticals Inc. across four factors: quality 43/100, value 48/100, dividend 4/100. Its strongest factor is value.
6785 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $184.05M
- Revenue (TTM)
- $94.30K
- P/E
- —
- EPS
- -1.08
- Dividend yield
- 0.11%
- Beta (5Y)
- 0.13
- 52-week high
- NT$317.00
- 52-week low
- NT$88.10
- Avg volume (3M)
- —
- Shares outstanding
- 66.80M
- Employees
- 32
- Next earnings
- —
About Alar Pharmaceuticals Inc.
Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.
- ISIN
- TW0006785009
- Founded
- 2016
- Listed since
- Oct 5, 2020
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| NervGen Pharma Corp.NasdaqCM: NGEN | $186.01M | $1.73 | -2.81% |
| Yoda Pharmaceuticals Inc.TPEX: 7829 | $185.57M | NT$59.70 | +1.02% |
| Dawnrays Pharmaceutical (Holdings) LimitedSEHK: 2348 | $184.28M | HK$0.96 | -0.52% |
| Formosa Laboratories, Inc.TWSE: 4746 | $184.10M | NT$48.95 | +1.77% |
| Orient Pharma Co., Ltd.TPEX: 4166 | $183.94M | NT$24.20 | -0.82% |
| Samjin Pharmaceuticals Co., Ltd.KOSE: A005500 | $183.27M | ₩20,100.00 | +5.35% |
| Fidson Healthcare PlcNGSE: FIDSON | $180.69M | ₦83.00 | +1.22% |
| Oramed Pharmaceuticals Inc.NasdaqCM: ORMP | $180.12M | $4.33 | -3.56% |
Figures last refreshed Oct 11, 2026.